Tuberculosis - Pharmacological management

Hospital Pharmacist

Volumn 13, Issue 3, 2006, Pages 81-85

  Hand, Kieran ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CAPREOMYCIN; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; LEVOTHYROXINE; MACROLIDE; METHADONE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; ORAL CONTRACEPTIVE AGENT; PENICILLIN G; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ABDOMINAL PAIN; APPETITE DISORDER; ARTHRALGIA; COUNSELING; DRUG ABSORPTION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG PENETRATION; DRUG SAFETY; EPIGASTRIC DISCOMFORT; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEPATITIS; HUMAN; LIVER TOXICITY; LUNG TUBERCULOSIS; MEDICAL SOCIETY; MORTALITY; NATIONAL HEALTH SERVICE; NAUSEA; OPTIC NEURITIS; PATIENT COMPLIANCE; PERICARDITIS; PERIPHERAL NEUROPATHY; PRESCRIPTION; PRURITUS; REVIEW; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT WITHDRAWAL; TUBERCULOSIS; TUBERCULOUS MENINGITIS; UNITED KINGDOM; UNITED STATES; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 33645293710     PISSN: 13527967     EISSN: 13527967     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Grange JM, Zumla A. Antituberculosis agents. In: Cohen J, Powderly WG (editors). Infectious diseases. London: Mosby;2004. pp1851-66.
2. Fitzgerald D, Haas DW. Mycobacterium tuberculosis. In: Mandell GL., Bennett JE, Dolin R (editors). Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone;2005. pp 2852-87.
3. Murray CJ, DeJonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991;338:1305-08.
4. Flores AR, Parsons LM, Pavelka MS, Jr. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology 2005;151:521-32.
5. Kucers A, Crowe SM, Grayson ML, Hoy JF. The use of antibiotics. Oxford: Butterworth Heinemann;1997.
6. Gelband H. Regimens of less than six months for treating tuberculosis. The Cochrane Database of Systematic Reviews. Issue 4; 1999.
7. Gravendeel JM, Asapa AS, Becx-Bleumink M, Vrakking HA. Preliminary results of an operational field study to compare side-effects, complaints and treatment results of a single-drug short-course regimen with a four-drug fixed-dose combination (4FDC) regimen in South Sulawesi, Republic of Indonesia. Tuberculosis (Edinb)2003;83:183-6.
8. Blumberg HM, Burrnan WJ, Chaisson RE, Daley CI, Etkind SC, Friedman LN et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. American Journal of Respiratory and Critical Care Medicine 2003;167:603-62.
9. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. New England Journal of Medicine 2004;351:1741-51.
10. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-99.
11. Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DJ. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM 2004;97:525-35.
12. World Health Organization. Global tuberculosis control: surveillance, planning, financing 2004. Geneva, Switzerland: WHO: 2004.
13. Omerod LP, Horsfield N, Green RM. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000. International Journal of Tuberculosis and Lung Disease 2002;6:662-65.
14. Jindani A, Nunn AJ, Enarson DA. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 2004;364:1244-51.
15. Castelo A, Jardim JR, Goihman S, Kalckman AS, Dalboni MA, da Silva EA et al. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. Lancet 1989;2:1173-76.
16. Chambers HF, Moreau D, Yajko D, Miick C, Wagner C, Hackbartn C, et al. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrobial Agents and Chemotherapy 1995;39: 2620-24.
17. Nadler JP, Berger J, Nord JA, Cofsky R, Saxena M. Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest 1991:99:1025-26.